Victor Oguoma

Senior Research Fellow (Epidemiology & Biostatistics)

Accepting PhD Students


Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Dr Victor M. Oguoma (BSc, MScPH, MBiostat, PhD) is a Senior Research Fellow (Epidemiology & Biostatistics) at the Health Research Institute, University of Canberra (HRI-UC). He has degrees/training in medical/public health parasitology/entomology, cardiometabolic disease epidemiology, and biostatistics. Before joining HRI-UC, he held Senior Research Officer in biostatistics position at the Menzies School of Health Research in Darwin, where he led/contributed to the design, implementation, and analyses of large scale randomised controlled trials (RCTs) and epidemiological studies in the Indigenous populations of Australia and sub-Sahara Africa. He has over 10 years of experience in public health, epidemiological, and applied biostatistics research across sectors - Non-governmental organisations and academia in Nigeria and Australia. In collaboration with other researchers, he has attracted over $3M in competitive National Health & Medical Research Council (NHMRC) and International-funded collaborative research grants and holds honorary research fellow appointments at the Menzies School of Health Research in Darwin and Dasman Diabetes Institute in Kuwait. He is an Editorial Board member of BMC Public Health journal. 

Research Interests

* Biostatistics
* Cardiovascular disease risk factors classification
* Indigenous, migrant and international health
* Infectious diseases epidemiology (malaria, otitis media, etc)
* RCTs and epidemiological study design/analyses
* Stepped wedge cluster randomised trial design/analyses
* Health indicator and health surveys

Research Projects

* 2020 - 2025 ‘Deadly Ears at Discharge’ - A hospital-based randomised controlled trial of an additional ear and hearing assessment to inform discharge planning by a trained Aboriginal Ear Health Worker in Aboriginal children with chronic ear infection. (NHMRC Clinical Trials and Cohort Studies Grant led by Menzies School of Health Research) (CI-E)

* 2018 - 2021 A randomised trial of an intensive education intervention using network of involved diabetes patients to improve glycaemic control of type 2 diabetes patients - Nigeria. Bringing Research in Diabetes to Global Environments and Systems programme (BRIDGES 2) - Funded by the International Diabetes Federation (IDF) and Eli Lilly and Company (Lilly), led by Novena University ~ (CI-B)

* 2018 - 2021 A community-based randomised trial of lifestyle intervention using targeted shared care approach on pregnancy outcomes in Nigerian women with gestational diabetes mellitus but without diabetes mellitus - Nigeria. Bringing Research in Diabetes to Global Environments and Systems programme (BRIDGES 2) - Funded by the International Diabetes Federation (IDF) and Eli Lilly and Company (Lilly) led by University of Nigeria(CI-F)

Education/Academic qualification

Master, Macquarie University

… → 2019

PhD, Charles Darwin University

… → 2017

Master, Nnamdi Azikiwe University

… → 2010

Bachelor, Nnamdi Azikiwe Univerity

… → 2006

External positions

Honorary Fellow, Dasman Diabetes Institute

1 Oct 2020 → …

Honorary Fellow, Menzies School of Health Research

1 Mar 2020 → …

Senior Research Officer in Biostatistics, Menzies School of Health Research

30 Aug 201731 Dec 2019

Academic Tutor, School of Psychological and Clinical Sciences, Charles Darwin University

1 Aug 201331 Dec 2017


Dive into the research topics where Victor Oguoma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 9 Similar Profiles


Recent external collaboration on country level. Dive into details by clicking on the dots or
  • Anthropometric cut-points for discriminating diabetes and metabolic syndrome among Arabs and Asians: the Kuwait Diabetes Epidemiology Program

    Oguoma, V. M., Coffee, N. T., Alsharrah, S., Abu-farha, M., Al-refaei, F. H., Alkandari, A., Al-mulla, F. & Daniel, M., 4 Mar 2021, In: British Journal of Nutrition. p. 1-25 25 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
  • Can acute cough characteristics from sound recordings differentiate common respiratory illnesses in children? A comparative prospective study

    Bisballe-Müller, N., Chang, A. B., Plumb, E. J., Oguoma, V. M., Halken, S. & McCallum, G. B., Jan 2021, In: Chest. 159, 1, p. 259-269 11 p.

    Research output: Contribution to journalArticlepeer-review

  • Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019

    Haile, L. M., Kamenov, K., Briant, P. S., Orji, A. U., Steinmetz, J. D., Abdoli, A., Abdollahi, M., Abu-gharbieh, E., Afshin, A., Ahmed, H., Ahmed Rashid, T., Akalu, Y., Alahdab, F., Alanezi, F. M., Alanzi, T. M., Al Hamad, H., Ali, L., Alipour, V., Al-raddadi, R. M., Amu, H. & 193 others, Arabloo, J., Arab-zozani, M., Arulappan, J., Ashbaugh, C., Atnafu, D. D., Babar, Z., Baig, A. A., Banik, P. C., Bärnighausen, T. W., Barrow, A., Bender, R. G., Bhagavathula, A. S., Bhardwaj, N., Bhardwaj, P., Bibi, S., Bijani, A., Burkart, K., Cederroth, C. R., Charan, J., Choudhari, S. G., Chu, D., Couto, R. A. S., Dagnew, A. B., Dagnew, B., Dahlawi, S. M. A., Dai, X., Dandona, L., Dandona, R., Desalew, A., Dhamnetiya, D., Dhimal, M. L., Dhimal, M., Doyle, K. E., Duncan, B. B., Ekholuenetale, M., Filip, I., Fischer, F., Franklin, R. C., Gaidhane, A. M., Gaidhane, S., Gallus, S., Ghamari, F., Ghashghaee, A., Ghozali, G., Gilani, S. A., Glavan, I., Golechha, M., Goulart, B. N. G., Gupta, V. B., Gupta, V. K., Hamidi, S., Hammond, B. R., Hay, S. I., Hayat, K., Heidari, G., Hoffman, H. J., Hopf, K. P., Hosseinzadeh, M., Househ, M., Hussain, R., Hwang, B., Iavicoli, I., Ibitoye, S. E., Ilesanmi, O. S., Irvani, S. S. N., Islam, S. M. S., Iwagami, M., Jacob, L., Jayapal, S. K., Jha, R. P., Jonas, J. B., Kalhor, R., Kameran Al-salihi, N., Kandel, H., Kasa, A. S., Kayode, G. A., Khalilov, R., Khan, E. A., Khatib, M. N., Kosen, S., Koyanagi, A., Kumar, G. A., Landires, I., Lasrado, S., Lim, S. S., Liu, X., Lobo, S. W., Lugo, A., Makki, A., Mendoza, W., Mersha, A. G., Mihretie, K. M., Miller, T. R., Misra, S., Mohamed, T. A., Mohammadi, M., Mohammadian-hafshejani, A., Mohammed, A., Mokdad, A. H., Moni, M. A., Neupane Kandel, S., Nguyen, H. L. T., Nixon, M. R., Noubiap, J. J., Nuñez-samudio, V., Oancea, B., Oguoma, V. M., Olagunju, A. T., Olusanya, B. O., Olusanya, J. O., Orru, H., Owolabi, M. O., Padubidri, J. R., Pakshir, K., Pardhan, S., Pashazadeh Kan, F., Pasovic, M., Pawar, S., Pham, H. Q., Pinheiro, M., Pourshams, A., Rabiee, N., Rabiee, M., Radfar, A., Rahim, F., Rahimi-movaghar, V., Rahman, M. H. U., Rahman, M., Rahmani, A. M., Rana, J., Rao, C. R., Rao, S. J., Rashedi, V., Rawaf, D. L., Rawaf, S., Renzaho, A. M. N., Rezapour, A., Ripon, R. K., Rodrigues, V., Rustagi, N., Saeed, U., Sahebkar, A., Samy, A. M., Santric-milicevic, M. M., Sathian, B., Satpathy, M., Sawhney, M., Schlee, W., Schmidt, M. I., Seylani, A., Shaikh, M. A., Shannawaz, M., Shiferaw, W. S., Siabani, S., Singal, A., Singh, J. A., Singh, J. K., Singhal, D., Skryabin, V. Y., Skryabina, A. A., Sotoudeh, H., Spurlock, E. E., Taddele, B. W., Tamiru, A. T., Tareque, M. I., Thapar, R., Tovani-palone, M. R., Tran, B. X., Ullah, S., Valadan Tahbaz, S., Violante, F. S., Vlassov, V., Vo, B., Vongpradith, A., Vu, G. T., Wei, J., Yadollahpour, A., Yahyazadeh Jabbari, S. H., Yeshaw, Y., Yigit, V., Yirdaw, B. W., Yonemoto, N., Yu, C., Yunusa, I., Zamani, M., Zastrozhin, M. S., Zastrozhina, A., Zhang, Z., Zhao, J. T., Murray, C. J. L., Davis, A. C., Vos, T. & Chadha, S., 13 Mar 2021, In: The Lancet. 397, p. 996-1009 14 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    2 Citations (Scopus)
    1 Downloads (Pure)
  • Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

    Leach, A. J., Mulholland, E. K., Santosham, M., Torzillo, P. J., McIntyre, P., Smith-Vaughan, H., Wilson, N., Arrowsmith, B., Beissbarth, J., Chatfield, M. D., Oguoma, V. M., Licciardi, P., Skull, S., Andrews, R., Carapetis, J., McDonnell, J., Krause, V. & Morris, P. S., 15 Feb 2021, In: Vaccine: X. 7, p. 1-33 33 p., 100086.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    13 Downloads (Pure)
  • Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial

    Beissbarth, J., Wilson, N., Arrowsmith, B., Binks, M. J., Oguoma, V., Kelly, L., Llewellyn, A., Kim Mulholland, E., Santosham, M., Morris, P. S., Smith-Vaughan, H. C., Cheng, A. C. & Leach, A. J., 23 Mar 2021, In: Vaccine. p. 1-10 10 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
If you made any changes in Pure these will be visible here soon.